Ülke: Avustralya
Dil: İngilizce
Kaynak: APVMA (Australian Pesticides and Veterinary Medicines Authority)
IMIDOCARB DIPROPIONATE
CEVA ANIMAL HEALTH PTY LTD
imidocarb dipropionate(120mg/mL)
PARENTERAL LIQUID/SOLUTION/SUSPENSION
IMIDOCARB DIPROPIONATE ANTIPROTOZOAL Active 120.0 mg/ml
100mL; 20mL
VM - Veterinary Medicine
CEVA ANIMAL HEALTH
CATTLE | BEEF | BOS INDICUS | BOS TAURUS | BOVINE | BUFFALO | BULL | BULLOCK | CALF | COW | DAIRY COW | HEIFER | STEER
ANTIBIOTIC & RELATED
TICK FEVER - BOVINE ANAPLASMOSIS | TICK FEVER - BOVINE BABESIOSIS | ANAPLASMA MARGINALE | BABESIA BIGEMINA | BABESIA BOVIS | RED WATER | REDWATER
Poison schedule: 6; Withholding period: WHP:Meat: Do not use less than 28 days before slaughter for human consumption. Milk: Do not use in lactating cows whe re milk or milk products may be used fo r human consumtion.; Host/pest details: CATTLE: [TICK FEVER - BOVINE ANAPLASMOSIS, TICK FEVER - BOVINE BABESIOSIS]; Poison schedule: 6; Withholding period: ; Host/pest details: CATTLE: [TICK FEVER - BOVINE ANAPLASMOSIS, TICK FEVER - BOVINE BABESIOSIS]; For the treatment and prevention of babesiosis and treatment of anaplasmosis in cattle.DO NOT USE in lactating cows where milk may be used or processed for human consumption.
Registered
2023-07-01
TEMPLATE FOR RELEVANT LABEL PARTICULARS (RLPs) (Veterinary Products) _Select appropriate: _ 0 New Product [gj Variation: 55235 JMIDOX INJECTION _Signal heading: _ POISON KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY _Product name: _ lmidox Injection _Active constituentls: _ lmidocarb Dipropionate 120 mg/mL (equivalent to Imidocarb 85 mg/mL) _Statement _ _of _ _claims: _ For the treatment and prevention of babesiosis and treatment of anaplasmosis in cattle. _Net contents: _ Multi dose vials of 20 mL & I 00 mL. _Directions for use heading: _ READ THE LEAFLET BEFORE USING THIS PRODUCT DIRECTIONS FOR USE: _Restraints: _ DO NOT USE in lactating cows where milk may be used or processed for human consumption. _Contraindications: _ NA _Precautions: _ Avoid intravenous administration. _Side effects: _ NA _Dosage _ & _administration: _ Use the contents of the vial within 28 days of initial broaching and discard any tmused portion. Stability studies have demonstrated lmidox Injection is stable for at least 28 days following first use, providing aseptic technique is followed. Use the contents of the vial within 28 days of initial broaching and discard any unused portion. Babesiosis: Prevention and sterilisation: 2.5 rnL per 100 kg bodyweight by subcutaneous injection. Irnidox Injection provides protection against babesiosis for up to 4 weeks. Treatment: I mL per 100 kg bodyweight by subcutaneous injection. Very severe cases may require a second dose 24 hours following the first injection. Ananlasmosis: 2.5 mL per 100 kg bodyweight by subcutaneous injection. _General directions: _ PHARMACOLOGY Imidocarb dipropionate is a derivative ofthe carbanilide antiprotozoals. Although the exact mode of action of the drug is not known a possible mechanism is interference with cellular repair and replication through binding with DNA. Imidocarb is highly effective against infections caused by _Babesia _ and _Anaplasma _ spp. CLINICAL APPLICATION Babesiosis, also known as tick fever or redwater, is caused by tick-borne protozoan p Belgenin tamamını okuyun
PAGE 1 OF 2 MATERIAL SAFETY DATA SHEET: 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING PRODUCT NAME : Imidox injection OTHER NAMES : Imidocarb Dipropionate RECOMMENDED USE: FOR ANIMAL TREATMENT ONLY. For subcutaneous injection for the treatment and prevention of Babesiosis in cattle and sheep, and the treatment of Anaplasmosis in cattle. MANUFACTURER COMPANY DETAILS: Parnell Manufacturing Pty Ltd ADDRESS Unit 4, Century Estate 476 Gardeners Road Alexandria, NSW 2015 Australia TELEPHONE NUMBER 61 (0)2-9667 4411 EMERGENCY TELEPHONE NUMBER 61 (0)2-9667 4411 (Business Hours) FACSIMILE NUMBER 61 (0)2-9667 4139 2. HAZARDS IDENTIFICATION Hazardous substance according to criteria of Worksafe Australia. 3. COMPOSITION/INFORMATION ON INGREDIENTS CHEMICAL ENTITY CAS NUMBER PROPORTION Imidocarb Dipropionate 55750-06-6 12% w/v Propionic Acid 79-09-4 <5% w/v Water For Injections 7732-18-5 To 100% 4. FIRST AID MEASURES SWALLOWED: Do not induce vomiting. Rinse out mouth with water. Seek medical attention immediately. EYE: If in eyes, hold eyes open and immediately flood with water for at least 15 minutes. Seek medical assistance. SKIN: If skin contact occurs remove contaminated clothing and wash skin thoroughly with soap and water. INHALED: Remove patient to fresh air. Rinse mouth and nose with water if required. Seek medical attention if required. FIRST AID FACILITIES: No specific first aid facilities required. ADVICE TO DOCTOR: Treat symptomatically as required. Neurological disorders may be aggravated by exposure to this product. 5. FIRE-FIGHTING MEASURES Not likely to contribute to a fire. Heating of the product results in increased pressure in a sealed container, which may lead to bursting of the container. 6. ACCIDENTAL RELEASE MEASURES Clean up spilled material with absorbent. Flush contaminated area with hot water and detergent. Dispose of waste in accordance with local, state or federal laws. 7. HANDLING AND STORAGE HANDLING: Avoid contact with eyes, skin and clothing. STORAGE: Store betwe Belgenin tamamını okuyun